J.D. Vance: Wall Street Will Tank Bonds to Sabotage Trump

J.D. Vance just dropped a bombshell: With Trump in office, Wall Street could drive the bond market into a death spiral—and your savings might be the first to get crushed.

Brian Concannon Biography and Net Worth

Director of CONMED

BRIAN P. CONCANNON has served as a Director of the Company since July 2013. Mr. Concannon served as President and CEO of Haemonetics Corporation, a publicly traded company (NYSE: HAE) headquartered in Braintree, Massachusetts, that provides blood management technologies and services to hospitals, blood collectors and plasma biopharmaceutical companies worldwide from April 2009 to October 2015. He joined Haemonetics in 2003 and served in various roles to include the President, Global Markets in 2006 and the Chief Operating Officer in 2007-2009. In April 2009, Mr. Concannon was promoted to President and Chief Executive Officer, and elected to the Haemonetics board of directors. Immediately prior to joining Haemonetics, Mr. Concannon was the President, Northeast Region, for Cardinal Health Medical Products and Services where he was employed since 1998. From 1985 to 1998, he was employed by American Hospital Supply Corporation, Baxter Healthcare Corp and Allegiance Healthcare in a series of sales and operations management positions of increasing responsibility. He has served in leadership roles within the healthcare industry for more than 30 years. Mr. Concannon is also a member of the board of directors of South Shore Health since January 2014 and was elected Vice-Chair in January 2017. Mr. Concannon was also appointed as the Civilian Aide to the Secretary of the Army for Massachusetts in October 2017. Mr. Concannon is a 1979 graduate of West Point. The Board of Directors has determined that Mr. Concannon is independent within the meaning of the rules of the Securities and Exchange Commission.

Mr. Concannon’s qualifications for election to CONMED’s Board include his experience as a former CEO and director of a publicly-traded medical device company, and the former president of a distribution company. Mr. Concannon offers industry experience from a sales and marketing perspective. He has the ability and willingness to serve on a Board, and the correct fit to work in a collegial manner with the other directors.

What is Brian Concannon's net worth?: The estimated net worth of Brian Concannon is at least $674,360.40 as of June 7th, 2023. Mr. Concannon owns 9,335 shares of CONMED stock worth more than $674,360 as of November 18th. This net worth evaluation does not reflect any other investments that Mr. Concannon may own. Learn More about Brian Concannon's net worth.
How do I contact Brian Concannon?: The corporate mailing address for Mr. Concannon and other CONMED executives is 525 FRENCH ROAD, UTICA NY, 13502. CONMED can also be reached via phone at (727) 392-6464. Learn More on Brian Concannon's contact information.
Has Brian Concannon been buying or selling shares of CONMED?: Brian Concannon has not been actively trading shares of CONMED within the last three months. Most recently, Brian Concannon sold 812 shares of the business's stock in a transaction on Wednesday, June 7th. The shares were sold at an average price of $129.01, for a transaction totalling $104,756.12. Following the completion of the sale, the director now directly owns 9,335 shares of the company's stock, valued at $1,204,308.35. Learn More on Brian Concannon's trading history.
Who are CONMED's active insiders?: CONMED's insider roster includes Pat Beyer (Insider), Brian Concannon (Director), Todd Garner (CFO), Curt Hartman (Chairman of the Board, CEO & President), Daniel Jonas (Insider), John Kennedy (EVP), Stanley Peters, III (VP), Peter Shagory (EVP), and Mark Tryniski (Director). Learn More on CONMED's active insiders.
Are insiders buying or selling shares of CONMED?: In the last twelve months, CONMED insiders bought shares 3 times. They purchased a total of 6,442 shares worth more than $446,732.92. In the last twelve months, insiders at the sold shares 2 times. They sold a total of 6,300 shares worth more than $540,119.00. The most recent insider tranaction occured on June, 14th when insider Stanley W Peters III sold 4,000 shares worth more than $287,280.00. Insiders at CONMED own 6.8% of the company. Learn More about insider trades at CONMED.
Information on this page was last updated on 6/14/2024.

Brian Concannon Insider Trading History at CONMED

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
6/7/2023	Sell	812	$129.01	$104,756.12	9,335
5/1/2023	Sell	2,072	$125.00	$259,000.00	9,812

Brian Concannon Buying and Selling Activity at CONMED

CONMED Company Overview

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

Today's Range

Now: $72.24

$70.01

$72.93

50 Day Range

MA: $69.72

$61.80

$76.93

2 Week Range

Now: $72.24

$61.05

$117.27

Volume

335,900 shs

Average Volume

489,760 shs

Market Capitalization

$2.23 billion

P/E Ratio

17.16

Dividend Yield

1.11%

Beta

1.45

J.D. Vance: Wall Street Will Tank Bonds to Sabotage Trump

From Golden Crest | Ad